English 
Deutsch 
Dr. Sennewald named as distributor for Novac7 mobile linear accelerator 
The Gold Standard in Hyperthermia 
Novac7 – The first mobile electron linear accelerator for IORT 
Breast carcinoma
The results of a multi-centric clinical Phase III study that included 306 patients with superficial localized breast carcinoma were published in 1996 by Vernon, Hand, Field, et.al (London, Great Britain) in the International Journal of Radiation Oncology, Biology, Physics. The results showed that the rate of complete remission increased from 41% to 59%, and the recurrence-free survival rate from 30% to 50%, when comparing the combined hyperthermia and radiation therapy treatment with radiation therapy alone (refer to vol. 35, no. 4, pp. 731-744).
Previously irradiated patients
Clinical complete response rate
Local control
Udo Gaipl: Immunological and biological rationale for hyperthermia in cancer treatment